Kidney Week

Abstract: FR-PO125

Decrease in Platelet Count in Patients with AKI and Its Association with Major Adverse Kidney Events

Session Information

• AKI: Diagnosis and Outcomes
  October 25, 2024 | Location: Exhibit Hall, Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

• 102 AKI: Clinical, Outcomes, and Trials

Authors

• Chavez, Jonathan, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Jonathan Chavez, PhD

• Garcia-Garcia, Guillermo, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Guillermo Garcia-Garcia, MD, FASN

• Medina, Ramon, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Ramon Medina, MD

• Andrade, Zarahi, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Zarahi Andrade, DrMed

• Correa de León, Juárez, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Juárez Correa de León, MD

• Hernández, Eduardo Manuel, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Eduardo Manuel Hernández, MD

• Padilla Armas, Jorge Luis, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Jorge Luis Padilla Armas

• Ornelas Ruvalcaba, Rebeca Lizette, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Rebeca Lizette Ornelas Ruvalcaba, MD

• Cabrera Aguilar, Jose Said, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Jose Said Cabrera Aguilar, MD

• Martínez Gallardo González, Alejandro, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Alejandro Martínez Gallardo González

• Alcantar Vallin, Maria de la Luz, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Maria de la Luz Alcantar Vallin, MD

• Navarro Blackaller, Guillermo, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Guillermo Navarro Blackaller, MD

Background

A reduction in platelet count in critically ill patients is a marker of severity of the clinical condition. However, whether this association holds true in acute kidney injury (AKI) is unknown. We analyzed the association between platelet reduction in patients with AKI and major adverse kidney events (MAKE).

Methods

In this retrospective cohort, we included AKI patients at the Hospital Civil of Guadalajara, in Jalisco, Mexico. Patients were divided according to whether their platelet count fell >21% during the first 10 days. Our objectives were to analyze the associations between a platelet reduction >21% and MAKE at 10 days (MAKE10) or at 30-90 days (MAKE30-90) and death.

Results

From 2017 to 2023, 400 AKI patients were included, 134 of whom had a >21% reduction in platelet count. The mean age was 54 years, 60% were male, and 44% had sepsis. The mean baseline platelet count was 194 x 103 cells/mL, and 65% of the KDIGO3 patients met these criteria. Those who underwent hemodialysis (HD) had lower platelet counts. After multiple adjustments, a platelet reduction >21% was associated with MAKE10 (OR 4.2, CI 2.1-8.5) but not with MAKE30-90. The mortality risk increased 3-fold (OR 2.9, CI 1.1-7.7, p= 0.02) with a greater decrease in the platelets (<90 x 103 cells/mL). As the platelets decreased, the incidence of MAKE was more likely to increase. These associations lost significance when accounting for starting HD.

Conclusion

In our retrospective cohort of patients with AKI, a >21% reduction in platelet count was associated with MAKE. Our results are useful for generating hypotheses and motivating us to continue studying this association with a more robust design.